Details Basic Details Approval Date Tuesday, July 2, 2024 Original Posting Date Tuesday, August 20, 2024 Health Outcome(s) amyloid related imaging abnormality-edema (ARIA-E), amyloid related imaging abnormality-hemosiderin deposition (ARIA-H), intracerebral hemorrhage (ICH) Regulatory Link(s) (2) FDA Approval Package ARIA Memo